Overview
Multifocal atrial tachycardia (MAT) is characterized by rapid, irregular heartbeats originating from multiple ectopic atrial foci, often complicating chronic lung or cardiac diseases. It poses significant hemodynamic challenges and requires prompt management to restore sinus rhythm and stabilize patients 13.Diagnosis
Clinical Presentation: Rapid, irregular heart rate often exceeding 100 bpm with varying P-wave morphology 13.
Electrocardiogram (ECG): Essential for identifying multiple P-wave morphologies and irregular RR intervals 13.
Underlying Conditions: Commonly associated with chronic obstructive pulmonary disease, congestive heart failure, and electrolyte imbalances 125.
Laboratory Tests: Assess electrolytes (especially magnesium and potassium), arterial blood gases, and cardiac biomarkers 25.Management
First-Line Treatments:
- Amiodarone: Intravenous (450-900 mg over 2 hours) or oral (600 mg/day) for effective conversion to sinus rhythm 1.
- Magnesium Sulphate: Intravenous or intramuscular administration for rapid rhythm conversion 25.
Adjunctive Treatments:
- Metoprolol: Oral dosing (25-50 mg) effectively reduces heart rate and restores sinus rhythm in patients with corrected hypoxia and electrolyte imbalances 3.
- Verapamil: Intravenous administration (up to 1 mg/min) decreases heart rate; calcium pretreatment may minimize hypotension 4.Special Populations
Elderly: Commonly affected; treatment efficacy similar to younger adults but monitor closely for adverse effects 1.
Comorbidities: Patients with chronic obstructive pulmonary disease and congestive heart failure may benefit from magnesium-sparing diuretics to prevent magnesium deficiency 2.Key Recommendations
Use Amiodarone for Conversion: Intravenous amiodarone (450-900 mg over 2 hours) or oral amiodarone (600 mg/day) is effective for converting MAT to sinus rhythm (Evidence: Strong 1).
Consider Magnesium Sulphate: Parenteral magnesium sulphate can rapidly restore sinus rhythm, with intramuscular administration showing quicker efficacy (Evidence: Moderate 25).
Monitor Electrolytes: Correct electrolyte imbalances, particularly magnesium and potassium, before and during treatment to stabilize cardiac rhythm (Evidence: Moderate 25).
Utilize Beta-Blockers: Oral metoprolol can effectively control heart rate in MAT patients with corrected underlying metabolic disturbances (Evidence: Moderate 3).
Evaluate Verapamil Use: Intravenous verapamil can reduce heart rate; consider calcium pretreatment to mitigate hypotension (Evidence: Weak 4).References
1 Kouvaras G, Cokkinos DV, Halal G, Chronopoulos G, Ioannou N. The effective treatment of multifocal atrial tachycardia with amiodarone. Japanese heart journal 1989. link
2 Cohen L, Kitzes R, Shnaider H. Multifocal atrial tachycardia responsive to parenteral magnesium. Magnesium research 1988. link
3 Arsura EL, Solar M, Lefkin AS, Scher DL, Tessler S. Metoprolol in the treatment of multifocal atrial tachycardia. Critical care medicine 1987. link
4 Salerno DM, Anderson B, Sharkey PJ, Iber C. Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. Annals of internal medicine 1987. link
5 Iseri LT, Fairshter RD, Hardemann JL, Brodsky MA. Magnesium and potassium therapy in multifocal atrial tachycardia. American heart journal 1985. link90458-2)